Pelvic floor disorders in women with gynecologic malignancy

Curr Opin Obstet Gynecol. 2018 Dec;30(6):446-450. doi: 10.1097/GCO.0000000000000500.

Abstract

Purpose of review: This article serves as an update on issues relating to the intersection of pelvic floor disorders and gynecology oncology.

Recent findings: Gynecologic cancer survivors experience pelvic floor disorders (PFDs) at a higher rate than their age-matched peers, often because of shared risk factors and as sequelae of cancer treatment. Concomitant pelvic floor and oncologic surgery can serve as a method to promote quality of life. Studies have demonstrated concomitant surgery to be well tolerated in appropriately selected patients, but only about 2% of oncologic surgeries are coordinated to include the treatment of PFDs. Conversely, women undergoing surgery for PFD have a low, but real risk of occult malignancy. Therefore, preoperative counseling is warranted in select populations. This article will discuss the management of concurrent PFDs and gynecologic malignancies.

Summary: Healthcare providers should be familiar with screening, management and referral of women with pelvic floor disorders in the gynecologic oncology population.

Publication types

  • Review

MeSH terms

  • Female
  • Genital Neoplasms, Female / surgery*
  • Gynecologic Surgical Procedures / adverse effects*
  • Gynecologic Surgical Procedures / statistics & numerical data
  • Humans
  • Pelvic Floor Disorders / epidemiology
  • Pelvic Floor Disorders / etiology
  • Pelvic Floor Disorders / surgery*
  • Postoperative Complications / surgery*
  • Prevalence
  • Risk Factors
  • Urologic Surgical Procedures / statistics & numerical data*